Literature for peptidase M28.012: glutamate carboxypeptidase III

(Topics flags: S Structure, P Specificity, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2023
1. Lee,Z., Heston,W.D., Wang,X. and Basilion,J.P.
   GCP III is not the "off-target" for urea-based PSMA ligands
   Eur J Nucl Med Mol Imaging50, 2944-2946. PubMed  Europe PubMed DOI
2. Lucaroni,L., Georgiev,T., Prodi,E., Puglioli,S., Pellegrino,C., Favalli,N., Prati,L., Manz,M.G., Cazzamalli,S., Neri,D., Oehler,S. and Bassi,G.
   Cross-reactivity to glutamate carboxypeptidase III causes undesired salivary gland and kidney uptake of PSMA-targeted small-molecule radionuclide therapeutics
   Eur J Nucl Med Mol Imaging50, 957-961. PubMed  Europe PubMed DOI
2020
3. Arteaga Cabeza,O., Zhang,Z., Smith Khoury,E., Sheldon,R.A., Sharma,A., Zhang,F., Slusher,B.S., Kannan,R.M., Kannan,S. and Ferriero,D.M.
   Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury
   Neurobiol Dis148, 105201-105201. PubMed  Europe PubMed DOI  I
2016
4. Navratil,M., Tykvart,J., Schimer,J., Pachl,P., Navratil,V., Rokob,T.A., Hlouchova,K., Rulisek,L. and Konvalinka,J.
   Comparison of human glutamate carboxypeptidases II and III reveals their divergent substrate specificities
   FEBS J283, 2528-2545. PubMed  Europe PubMed DOI
2012
5. Hlouchova,K., Navratil,V., Tykvart,J., Sacha,P. and Konvalinka,J.
   GCPII variants, paralogs and orthologs
   Curr Med Chem19, 1316-1322. PubMed  Europe PubMed DOI
2011
6. Collard,F., Vertommen,D., Constantinescu,S., Buts,L. and Van Schaftingen,E.
   Molecular identification of beta-citrylglutamate hydrolase as glutamate carboxypeptidase 3
   J Biol Chem286, 38220-38230. PubMed  Europe PubMed DOI
2009
7. Hlouchova,K., Barinka,C., Konvalinka,J. and Lubkowski,J.
   Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III
   FEBS J276, 4448-4462. PubMed  Europe PubMed DOI  S
2007
8. Hlouchova,K., Barinka,C., Klusak,V., Sacha,P., Mlcochova,P., Majer,P., Rulisek,L. and Konvalinka,J.
   Biochemical characterization of human glutamate carboxypeptidase III
   J Neurochem101, 682-696. PubMed  Europe PubMed DOI  P
2004
9. Bzdega,T., Crowe,S.L., Ramadan,E.R., Sciarretta,K.H., Olszewski,R.T., Ojeifo,O.A., Rafalski,V.A., Wroblewska,B. and Neale,J.H.
   The cloning and characterization of a second brain enzyme with NAAG peptidase activity
   J Neurochem89, 627-635. PubMed  Europe PubMed DOI  I
10. Olszewski,R.T., Bukhari,N., Zhou,J., Kozikowski,A.P., Wroblewski,J.T., Shamimi-Noori,S., Wroblewska,B., Bzdega,T., Vicini,S., Barton,F.B. and Neale,J.H.
    NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR
    J Neurochem89, 876-885. PubMed  Europe PubMed DOI  I
1999
11. [YEAR:26-3-1999]Pangalos,M.N., Neefs,J.M., Somers,M., Verhasselt,P., Bekkers,M., van der Helm,L., Fraiponts,E., Ashton,D. and Gordon,R.D.
    Isolation and expression of novel human glutamate carboxypeptidases with N-acetylated alpha-linked acidic dipeptidase and dipeptidyl peptidase IV activity
    J Biol Chem274, 8470-8483. PubMed  Europe PubMed DOI